Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156247
Status:
COMPLETED
Last Update Posted:
2015-02-16
First Post:
2005-09-07
Brief Title:
Acitretin and Etanercept in Psoriasis
Sponsor:
University of Medicine and Dentistry of New Jersey
Organization:
Rutgers The State University of New Jersey
Study Overview
Official Title:
Pilot Single-Arm Study of the Effect of Adding Acitretin to Etanercept Therapy in Patients With Moderate to Severe Psoriasis Who Fail to Respond to Etanercept Monotherapy
Status:
COMPLETED
Status Verified Date:
2015-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine whether acitretin plus etanercept is more effective than etanercept alone in clearing psoriasis plaques in adults
Detailed Description:
This study will include patients with moderate to severe psoriasis who have been taking etanercept 50 mgweek for at least 3 months 12 weeks and have not achieved PASI 75 They will be given acitretin 25 mgday The combined treatment will occur over 6 months Subjects progress will be assessed monthly based on the improvement of their PASI and PGA scores
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None